160 related articles for article (PubMed ID: 24428911)
1. A dedicated microarray for in-depth analysis of pre-mRNA splicing events: application to the study of genes involved in the response to targeted anticancer therapies.
Pesson M; Eymin B; De La Grange P; Simon B; Corcos L
Mol Cancer; 2014 Jan; 13():9. PubMed ID: 24428911
[TBL] [Abstract][Full Text] [Related]
2. Human Papillomavirus 16 Oncoprotein Expression Is Controlled by the Cellular Splicing Factor SRSF2 (SC35).
McFarlane M; MacDonald AI; Stevenson A; Graham SV
J Virol; 2015 May; 89(10):5276-87. PubMed ID: 25717103
[TBL] [Abstract][Full Text] [Related]
3. Abnormal expression of the pre-mRNA splicing regulators SRSF1, SRSF2, SRPK1 and SRPK2 in non small cell lung carcinoma.
Gout S; Brambilla E; Boudria A; Drissi R; Lantuejoul S; Gazzeri S; Eymin B
PLoS One; 2012; 7(10):e46539. PubMed ID: 23071587
[TBL] [Abstract][Full Text] [Related]
4. Disease-associated mutation in SRSF2 misregulates splicing by altering RNA-binding affinities.
Zhang J; Lieu YK; Ali AM; Penson A; Reggio KS; Rabadan R; Raza A; Mukherjee S; Manley JL
Proc Natl Acad Sci U S A; 2015 Aug; 112(34):E4726-34. PubMed ID: 26261309
[TBL] [Abstract][Full Text] [Related]
5. Nuclear Speckle-related Protein 70 Binds to Serine/Arginine-rich Splicing Factors 1 and 2 via an Arginine/Serine-like Region and Counteracts Their Alternative Splicing Activity.
Kim CH; Kim YD; Choi EK; Kim HR; Na BR; Im SH; Jun CD
J Biol Chem; 2016 Mar; 291(12):6169-81. PubMed ID: 26797131
[TBL] [Abstract][Full Text] [Related]
6. A new function of the splicing factor SRSF2 in the control of E2F1-mediated cell cycle progression in neuroendocrine lung tumors.
Edmond V; Merdzhanova G; Gout S; Brambilla E; Gazzeri S; Eymin B
Cell Cycle; 2013 Apr; 12(8):1267-78. PubMed ID: 23518498
[TBL] [Abstract][Full Text] [Related]
7. Methylxanthines Increase Expression of the Splicing Factor SRSF2 by Regulating Multiple Post-transcriptional Mechanisms.
Shi J; Pabon K; Scotto KW
J Biol Chem; 2015 Jun; 290(24):14986-5003. PubMed ID: 25818199
[TBL] [Abstract][Full Text] [Related]
8. Identification of alternative splicing events regulated by the oncogenic factor SRSF1 in lung cancer.
de Miguel FJ; Sharma RD; Pajares MJ; Montuenga LM; Rubio A; Pio R
Cancer Res; 2014 Feb; 74(4):1105-15. PubMed ID: 24371231
[TBL] [Abstract][Full Text] [Related]
9. Relative strength of 5' splice-site strength defines functions of SRSF2 and SRSF6 in alternative splicing of Bcl-x pre-mRNA.
Choi N; Liu Y; Oh J; Ha J; Ghigna C; Zheng X; Shen H
BMB Rep; 2021 Mar; 54(3):176-181. PubMed ID: 33050987
[TBL] [Abstract][Full Text] [Related]
10. Activation of Cryptic 3' Splice-Sites by SRSF2 Contributes to Cassette Exon Skipping.
Moon H; Jang HN; Liu Y; Choi N; Oh J; Ha J; Zheng X; Shen H
Cells; 2019 Jul; 8(7):. PubMed ID: 31295920
[TBL] [Abstract][Full Text] [Related]
11. Caffeine regulates alternative splicing in a subset of cancer-associated genes: a role for SC35.
Shi J; Hu Z; Pabon K; Scotto KW
Mol Cell Biol; 2008 Jan; 28(2):883-95. PubMed ID: 18025108
[TBL] [Abstract][Full Text] [Related]
12. Regulation of SRp20 exon 4 splicing.
Jumaa H; Nielsen PJ
Biochim Biophys Acta; 2000 Nov; 1494(1-2):137-43. PubMed ID: 11072076
[TBL] [Abstract][Full Text] [Related]
13. Comparison of Affymetrix Gene Array with the Exon Array shows potential application for detection of transcript isoform variation.
Ha KCh; Coulombe-Huntington J; Majewski J
BMC Genomics; 2009 Nov; 10():519. PubMed ID: 19909511
[TBL] [Abstract][Full Text] [Related]
14. SC35 promotes splicing of the C5-V6-C6 isoform of CD44 pre-mRNA.
Loh TJ; Moon H; Cho S; Jung DW; Hong SE; Kim DH; Green MR; Zheng X; Zhou J; Shen H
Oncol Rep; 2014 Jan; 31(1):273-9. PubMed ID: 24173428
[TBL] [Abstract][Full Text] [Related]
15. A highly stable duplex structure sequesters the 5' splice site region of hnRNP A1 alternative exon 7B.
Blanchette M; Chabot B
RNA; 1997 Apr; 3(4):405-19. PubMed ID: 9085847
[TBL] [Abstract][Full Text] [Related]
16. SRSF2 directly inhibits intron splicing to suppresses cassette exon inclusion.
Moon H; Cho S; Loh TJ; Jang HN; Liu Y; Choi N; Oh J; Ha J; Zhou J; Cho S; Kim DE; Ye MB; Zheng X; Shen H
BMB Rep; 2017 Aug; 50(8):423-428. PubMed ID: 28712387
[TBL] [Abstract][Full Text] [Related]
17. SRSF2 promotes splicing and transcription of exon 11 included isoform in Ron proto-oncogene.
Moon H; Cho S; Loh TJ; Oh HK; Jang HN; Zhou J; Kwon YS; Liao DJ; Jun Y; Eom S; Ghigna C; Biamonti G; Green MR; Zheng X; Shen H
Biochim Biophys Acta; 2014 Nov; 1839(11):1132-40. PubMed ID: 25220236
[TBL] [Abstract][Full Text] [Related]
18. Splicing inhibition of U2AF65 leads to alternative exon skipping.
Cho S; Moon H; Loh TJ; Jang HN; Liu Y; Zhou J; Ohn T; Zheng X; Shen H
Proc Natl Acad Sci U S A; 2015 Aug; 112(32):9926-31. PubMed ID: 26216990
[TBL] [Abstract][Full Text] [Related]
19. HnRNP A1/A2 and SF2/ASF regulate alternative splicing of interferon regulatory factor-3 and affect immunomodulatory functions in human non-small cell lung cancer cells.
Guo R; Li Y; Ning J; Sun D; Lin L; Liu X
PLoS One; 2013; 8(4):e62729. PubMed ID: 23658645
[TBL] [Abstract][Full Text] [Related]
20. Exon array analysis using re-defined probe sets results in reliable identification of alternatively spliced genes in non-small cell lung cancer.
Langer W; Sohler F; Leder G; Beckmann G; Seidel H; Gröne J; Hummel M; Sommer A
BMC Genomics; 2010 Nov; 11():676. PubMed ID: 21118496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
